Literature DB >> 27239036

Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation.

Xiaoming Sun1, Yi Shi2, Tomohiro Akahoshi1, Mamoru Fujiwara1, Hiroyuki Gatanaga3, Christian Schönbach4, Nozomi Kuse1, Victor Appay5, George F Gao2, Shinichi Oka3, Masafumi Takiguchi6.   

Abstract

The mechanistic basis for the progressive accumulation of Y(135)F Nef mutant viruses in the HIV-1-infected population remains poorly understood. Y(135)F viruses carry the 2F mutation within RW8 and RF10, which are two HLA-A(∗)24:02-restricted superimposed Nef epitopes recognized by distinct and adaptable CD8(+) T cell responses. We combined comprehensive analysis of the T cell receptor repertoire and cross-reactive potential of wild-type or 2F RW8- and RF10-specific CD8(+) T cells with peptide-MHC complex stability and crystal structure studies. We find that, by affecting direct and water-mediated hydrogen bond networks within the peptide-MHC complex, the 2F mutation reduces both TCR and HLA binding. This suggests an advantage underlying the evolution of the 2F variant with decreased CD8(+) T cell efficacy. Our study provides a refined understanding of HIV-1 and CD8(+) T cell co-adaptation at the population level.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27239036     DOI: 10.1016/j.celrep.2016.05.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  Comparative analysis of CDR3 regions in paired human αβ CD8 T cells.

Authors:  Kun Yu; Ji Shi; Dan Lu; Qiong Yang
Journal:  FEBS Open Bio       Date:  2019-07-12       Impact factor: 2.693

3.  T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.

Authors:  Tomohiro Akahoshi; Hiroyuki Gatanaga; Nozomi Kuse; Takayuki Chikata; Madoka Koyanagi; Naoki Ishizuka; Chanson J Brumme; Hayato Murakoshi; Zabrina L Brumme; Shinichi Oka; Masafumi Takiguchi
Journal:  PLoS Pathog       Date:  2020-12-28       Impact factor: 6.823

4.  CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.

Authors:  Elisa Guo; Hailong Guo
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

5.  Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.

Authors:  Takayuki Chikata; Wayne Paes; Nozomi Kuse; Thomas Partridge; Hiroyuki Gatanaga; Yu Zhang; Kimiko Kuroki; Katsumi Maenaka; Nicola Ternette; Shinichi Oka; Persephone Borrow; Masafumi Takiguchi
Journal:  J Virol       Date:  2022-04-27       Impact factor: 6.549

6.  Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine.

Authors:  Nozomi Kuse; Yu Zhang; Takayuki Chikata; Hung The Nguyen; Shinichi Oka; Hiroyuki Gatanaga; Masafumi Takiguchi
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

Review 7.  Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.

Authors:  Kyle Saylor; Frank Gillam; Taylor Lohneis; Chenming Zhang
Journal:  Front Immunol       Date:  2020-02-24       Impact factor: 7.561

8.  Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.

Authors:  Yu Zhang; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Hayato Murakoshi; Masafumi Takiguchi
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

9.  Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.

Authors:  Nozomi Kuse; Hayato Murakoshi; Tomohiro Akahoshi; Takayuki Chikata; Katherine L James; Hiroyuki Gatanaga; Sarah L Rowland-Jones; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.